Helping patients understand gene test results for breast cancer
Part of Cancer, Skin clinical trials.
This study tests a tool to help people newly diagnosed with early-stage breast cancer better understand their gene test results. It is for patients who haven't yet decided about chemotherapy and want to learn more about their options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early-stage breast cancer that was completely removed with surgery
- Your cancer is estrogen receptor (ER) positive and HER-2 negative
- You and your doctor are unsure if chemotherapy should be added after surgery
- You agreed to a gene expression profile (GEP) test, which looks at your cancer's genes
- You can read, write, and speak Italian well
- You have internet access and a device like a smartphone, tablet, or computer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new educational materials about genetic testing for cancer patients. It aims to find the best ways to explain genetic testing to people from different backgrounds, especially Black, Latino, and non-Latino non-Black communities.
This study tests a video-based education approach that shares information differently depending on someone’s genetic test results. It may help people better understand cancer-related genetic information and what it could mean for them.
This study links breast tumor test results from MammaPrint and optional BluePrint (and full genetic data) with real-world clinical information to understand which new gene activity patterns matter. It may help future patients by improving how doctors use these tests to guide care.
This study looks at how genetic tests like Oncotype DX or Mammaprint are used to guide treatment decisions for people with early-stage, hormone receptor-positive (HR+) and HER2-negative breast cancer. It aims to help doctors choose between hormone therapy alone or chemotherapy plus hormone therapy.
This study is testing a new way to help women with breast cancer learn about and access fertility preservation options before starting chemotherapy. It looks specifically at whether information materials are understandable and helpful for all patients, including those with intellectual disabilities.
This trial studies what people and families think and understand about genetic test results, especially when results suggest a higher risk for disease. It may also include interviews and follow-up, and in some cases additional family testing if it fits the study’s goals.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.